glp-1 market forecast Analogues Size to Hit USD 1,062.90 Billion by 2035 GLP-1 Agonists Market Report 2025-2033,

The FDAs updated label now highlights the risk of ileus, a condition where the intestines cannot move food properly, which can lead to severe blockages

Wang et al., 2021), reduction of colonic cytotoxic T lymphocytes (Wang et al., 2020), and inhibition of lipid synthesis and transport genes (Zhang F

Novo Nordisk Eli Lilly

Final Thoughts GLP-1 medications represent a significant advance in the treatment of obesity and metabolic disease

While many people will likely respond positively to the medication, data suggests that tirzepatide and semaglutide are superior drugs for most patients

If you're planning pregnancy, discontinue treatment at least 2 months beforehand, as these medications remain in your system for extended periods